SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950103-20-017822
Filing Date
2020-09-14
Accepted
2020-09-14 08:01:51
Documents
16
Period of Report
2020-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp136480_8k.htm   iXBRL 8-K 45126
2 EXHIBIT 2.1 dp136480_ex0201.htm EX-2.1 556596
3 EXHIBIT 99.1 dp136480_ex9901.htm EX-99.1 40221
4 GRAPHIC image_001.jpg GRAPHIC 2108
5 GRAPHIC image_002.jpg GRAPHIC 2689
  Complete submission text file 0000950103-20-017822.txt   960355

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE gild-20200913.xsd EX-101.SCH 3180
7 XBRL LABEL FILE gild-20200913_lab.xml EX-101.LAB 34591
8 XBRL PRESENTATION FILE gild-20200913_pre.xml EX-101.PRE 22706
9 EXTRACTED XBRL INSTANCE DOCUMENT dp136480_8k_htm.xml XML 3509
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 201172319
SIC: 2836 Biological Products, (No Diagnostic Substances)